Advertisement
GLSI vs LPCN
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLSI is a Hold and LPCN is a Hold.
GLSI in downward trend: price may drop because broke its higher Bollinger Band on October 29, 2026
GLSI broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 40 similar instances where the stock broke above the upper band. In 36 of the 40 cases the stock fell afterwards. This puts the odds of success at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GLSI as a result. In 77 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.
The Moving Average Convergence Divergence Histogram (MACD) for GLSI turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 37 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 88%.
GLSI moved below its 50-day moving average on November 02, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GLSI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The Aroon Indicator for GLSI entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The 10-day moving average for GLSI crossed bullishly above the 50-day moving average on October 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 19 of 21 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +9.07% 3-day Advance, the price is estimated to grow further. Considering data from situations where GLSI advanced for three days, in 212 of 269 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. GLSI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 57 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 94 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: GLSI's P/B Ratio (71.438) is slightly higher than the industry average of (3.498). P/E Ratio (-9.541) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GLSI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
LPCN in -10.00% downward trend, declining for three consecutive days on October 23, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where LPCN declined for three days, in 273 of 316 cases, the price declined further within the following month. The odds of a continued downward trend are 86%.
Technical Analysis (Indicators)
Bearish Trend Analysis
LPCN moved below its 50-day moving average on October 08, 2026 date and that indicates a change from an upward trend to a downward trend.
The Aroon Indicator for LPCN entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where LPCN's RSI Oscillator exited the oversold zone, 34 of 40 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 85%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 61 of 69 cases where LPCN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.
The Momentum Indicator moved above the 0 level on November 05, 2026. You may want to consider a long position or call options on LPCN as a result. In 68 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
The Moving Average Convergence Divergence (MACD) for LPCN just turned positive on November 02, 2026. Looking at past instances where LPCN's MACD turned positive, the stock continued to rise in 34 of 41 cases over the following month. The odds of a continued upward trend are 83%.
Following a +9.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where LPCN advanced for three days, in 209 of 256 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
LPCN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 42 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.595) is normal, around the industry mean (3.498). P/E Ratio (-0.849) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (9.302) is also within normal values, averaging (440.869).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 82 (best 1 - 100 worst), indicating slightly worse than average price growth. LPCN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LPCN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
GLSI | LPCN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 94 Overvalued | 42 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 98 | |
PRICE GROWTH RATING 1..100 | 46 | 82 | |
P/E GROWTH RATING 1..100 | 57 | 17 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
LPCN's Valuation (42) in the Pharmaceuticals Other industry is somewhat better than the same rating for GLSI (94) in the null industry. This means that LPCN’s stock grew somewhat faster than GLSI’s over the last 12 months.
LPCN's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as GLSI (100) in the null industry. This means that LPCN’s stock grew similarly to GLSI’s over the last 12 months.
LPCN's SMR Rating (98) in the Pharmaceuticals Other industry is in the same range as GLSI (100) in the null industry. This means that LPCN’s stock grew similarly to GLSI’s over the last 12 months.
GLSI's Price Growth Rating (46) in the null industry is somewhat better than the same rating for LPCN (82) in the Pharmaceuticals Other industry. This means that GLSI’s stock grew somewhat faster than LPCN’s over the last 12 months.
LPCN's P/E Growth Rating (17) in the Pharmaceuticals Other industry is somewhat better than the same rating for GLSI (57) in the null industry. This means that LPCN’s stock grew somewhat faster than GLSI’s over the last 12 months.
| GLSI | LPCN | |
|---|---|---|
| RSI ODDS (%) | N/A | 3 days ago 85% |
| Stochastic ODDS (%) | 3 days ago 86% | 3 days ago 88% |
| Momentum ODDS (%) | 3 days ago 85% | 3 days ago 82% |
| MACD ODDS (%) | 3 days ago 88% | 3 days ago 83% |
| TrendWeek ODDS (%) | 3 days ago 86% | 3 days ago 80% |
| TrendMonth ODDS (%) | 3 days ago 87% | 3 days ago 86% |
| Advances ODDS (%) | 11 days ago 79% | 3 days ago 82% |
| Declines ODDS (%) | 6 days ago 85% | 17 days ago 86% |
| BollingerBands ODDS (%) | 3 days ago 90% | 3 days ago 84% |
| Aroon ODDS (%) | 3 days ago 84% | 3 days ago 81% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GLSI’s FA Score shows that 0 FA rating(s) are green while LPCN’s FA Score has 1 green FA rating(s).
- GLSI’s FA Score: 0 green, 5 red.
- LPCN’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GLSI’s TA Score shows that 3 TA indicator(s) are bullish while LPCN’s TA Score has 6 bullish TA indicator(s).
- GLSI’s TA Score: 3 bullish, 6 bearish.
- LPCN’s TA Score: 6 bullish, 3 bearish.
Price Growth
GLSI (@Biotechnology) experienced а -12.87% price change this week, while LPCN (@Biotechnology) price change was +9.03% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -2.35%. For the same industry, the average monthly price growth was -10.88%, and the average quarterly price growth was -18.54%.
Reported Earning Dates
GLSI is expected to report earnings on Nov 13, 2026.
LPCN is expected to report earnings on Mar 11, 2027.
Industries' Descriptions
@Biotechnology (-2.35% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
GLSI and
Correlation & Price change
A.I.dvisor indicates that over the last year, GLSI has been loosely correlated with ABUS. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if GLSI jumps, then ABUS could also see price increases.
| Ticker / NAME | Correlation To GLSI | 1D Price Change % | ||
|---|---|---|---|---|
| GLSI | 100% | +3.55% | ||
| ABUS - GLSI | 35% Loosely correlated | -0.41% | ||
| IPSC - GLSI | 35% Loosely correlated | +11.26% | ||
| RXRX - GLSI | 34% Loosely correlated | +0.57% | ||
| RZLT - GLSI | 34% Loosely correlated | +6.59% | ||
| ALLO - GLSI | 34% Loosely correlated | -4.59% | ||
More | ||||
LPCN and
Correlation & Price change
A.I.dvisor indicates that over the last year, LPCN has been loosely correlated with SPRY. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if LPCN jumps, then SPRY could also see price increases.
| Ticker / NAME | Correlation To LPCN | 1D Price Change % | ||
|---|---|---|---|---|
| LPCN | 100% | +2.61% | ||
| SPRY - LPCN | 63% Loosely correlated | +5.28% | ||
| HYFT - LPCN | 43% Loosely correlated | +6.00% | ||
| ELAB - LPCN | 42% Loosely correlated | -2.42% | ||
| ZNTL - LPCN | 36% Loosely correlated | +0.58% | ||
| GLSI - LPCN | 32% Poorly correlated | +3.55% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| EMEQ | 55.23 | 1.43 | +2.66% |
| Nomura ETF Trust Nomura Focused Emerging Markets Equity ETF (EMEQ) | |||
| CNEQ | 35.34 | 0.72 | +2.08% |
| Alger Concentrated Equity ETF (CNEQ) | |||
| ARVR | 55.45 | 0.54 | +0.98% |
| First Trust Indxx Metaverse ETF (ARVR) | |||
| DRIP | 38.92 | 0.22 | +0.57% |
| Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X ETF (DRIP) | |||
| NMB | 24.24 | 0.07 | +0.29% |
| Simplify National Muni Bond ETF (NMB) | |||